Position in RVTY
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$1,232,427
+$351,684 QoQ
Shares Held
11,077
+10.2% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#200
of 542 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in RVTY Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026CARY STREET PARTNERS FINANCIAL LLC holds $26,797,423 across 11 Diagnostics & Research names. RVTY ranks #5 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
33,339 | $16,714,841 | |
| 2 | LH |
Labcorp Holdings Inc.
|
14,623 | $4,094,440 | |
| 3 | DHR |
Danaher Corp /De/
|
9,293 | $1,770,130 | |
| 4 | NTRA |
Natera, Inc.
|
5,387 | $1,462,301 | |
| 5 | RVTY |
Revvity, Inc.
This page
|
11,077 | $1,232,427 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
910 | $481,926 | |
| 7 | A |
Agilent Technologies, Inc.
|
3,326 | $441,791 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
849 | $164,043 |
All Filings in RVTY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,232,427 | 11,077 | Shares | Defined | 2026-07-17 | |
| 2026-03-31 | $880,743 | 10,053 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $865,041 | 8,941 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $771,319 | 8,800 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $622,585 | 6,437 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $571,108 | 5,398 | Shares | Defined | 2025-05-09 | |
| No filing history on record for this holder in this stock. | ||||||